Home Healthcare Biotechnology Cell Therapy Raw Materials Market

Cell Therapy Raw Materials Market Size, Share & Trends Analysis Report By Product (Media, Sera, Cell Culture Supplements, Antibodies, Reagents & Buffers, Others), End Use (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 24, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Cell Therapy Raw Materials Market Size Analysis
    1. Introduction
    2. Cell Therapy Raw Materials Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Media
      2. Sera
      3. Cell Culture Supplements
      4. Antibodies
      5. Reagents & Buffers
      6. Others
    3. Cell Therapy Raw Materials Market Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
      1. Biopharmaceutical & Pharmaceutical Companies
      2. CROs & CMOs
      3. Others
  7. North America Cell Therapy Raw Materials Market Size Analysis
    1. Introduction
    2. Cell Therapy Raw Materials Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Media
      2. Sera
      3. Cell Culture Supplements
      4. Antibodies
      5. Reagents & Buffers
      6. Others
    3. Cell Therapy Raw Materials Market Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
      1. Biopharmaceutical & Pharmaceutical Companies
      2. CROs & CMOs
      3. Others
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
  8. Europe Cell Therapy Raw Materials Market Size Analysis
    1. Introduction
    2. Cell Therapy Raw Materials Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Media
      2. Sera
      3. Cell Culture Supplements
      4. Antibodies
      5. Reagents & Buffers
      6. Others
    3. Cell Therapy Raw Materials Market Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
      1. Biopharmaceutical & Pharmaceutical Companies
      2. CROs & CMOs
      3. Others
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    6. France
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
  9. APAC Cell Therapy Raw Materials Market Size Analysis
    1. Introduction
    2. Cell Therapy Raw Materials Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Media
      2. Sera
      3. Cell Culture Supplements
      4. Antibodies
      5. Reagents & Buffers
      6. Others
    3. Cell Therapy Raw Materials Market Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
      1. Biopharmaceutical & Pharmaceutical Companies
      2. CROs & CMOs
      3. Others
    4. China
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    7. India
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    9. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    10. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    11. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
  10. Middle East and Africa Cell Therapy Raw Materials Market Size Analysis
    1. Introduction
    2. Cell Therapy Raw Materials Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Media
      2. Sera
      3. Cell Culture Supplements
      4. Antibodies
      5. Reagents & Buffers
      6. Others
    3. Cell Therapy Raw Materials Market Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
      1. Biopharmaceutical & Pharmaceutical Companies
      2. CROs & CMOs
      3. Others
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
  11. LATAM Cell Therapy Raw Materials Market Size Analysis
    1. Introduction
    2. Cell Therapy Raw Materials Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Media
      2. Sera
      3. Cell Culture Supplements
      4. Antibodies
      5. Reagents & Buffers
      6. Others
    3. Cell Therapy Raw Materials Market Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
      1. Biopharmaceutical & Pharmaceutical Companies
      2. CROs & CMOs
      3. Others
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Media
        2. Sera
        3. Cell Culture Supplements
        4. Antibodies
        5. Reagents & Buffers
        6. Others
      3. Market Size & Forecast End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Others
  12. Competitive Landscape
    1. Cell Therapy Raw Materials Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Thermo Fisher Scientific
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Merck KGaA
    3. Sartorius AG
    4. STEMCELL Technologies
    5. Lonza
    6. Miltenyi Biotec
    7. Bio-Techne
    8. BD
    9. GE HealthCare
    10. Corning Incorporated
    11. Sartorius CellGenix GmbH
    12. Charles River Laboratories
    13. ACROBiosystems
    14. Actylis
    15. RoosterBio, Inc.
    16. PromoCell
    17. Repligen Corporation
    18. Eppendorf SE
    19. PBS Biotech, Inc.
    20. Others
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.